Document is current
Any future updates will be listed below
-
Authors
Wlodarek, Lukasz
Cao, Feng
Alibhai, Faisal J.
Fekete, Adam
Noyan, Nima
Tobin, Stephanie W.
Marvasti, Tina B.
Wu, Jun
Li, Shu-Hong
Weisel, Richard D.
Wang, Lu-Yang
Jia, Zhengping
Li, Ren-Ke https://orcid.org/0000-0002-8584-5736
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (332652)
Ontario Research Fund (RE07-010)
- License Information
-
More Information
Article History
Received: 4 July 2019
Accepted: 17 December 2019
First Online: 7 February 2020
Ethics approval and consent to participate
: The Animal Care Committee of the University Health Network approved all experimental procedures, which were carried out according to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 2011). For human data, male and female patients older than 18 years of age who were scheduled for non-emergency open-heart surgery were consented for the study. The research ethics board of the University Health Network approved all investigations involving human participants. Patients with known active malignancies within the past 3 years or simultaneous participation in another study with an investigational pharmacological agent were not recruited.
: Not applicable.
: The authors declare that they have no competing interests.
